73 related articles for article (PubMed ID: 9353413)
1. Carvedilol, a multiple-action neurohumoral antagonist, inhibits mitogen-activated protein kinase and cell cycle progression in vascular smooth muscle cells.
Sung CP; Arleth AJ; Eichman C; Truneh A; Ohlstein EH
J Pharmacol Exp Ther; 1997 Nov; 283(2):910-7. PubMed ID: 9353413
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol inhibits platelet-derived growth factor-induced extracellular matrix synthesis by inhibiting cellular reactive oxygen species and mitogen-activated protein kinase activation.
Park J; Ha H; Kim MS; Ahn HJ; Huh KH; Kim YS
J Heart Lung Transplant; 2006 Jun; 25(6):683-9. PubMed ID: 16730574
[TBL] [Abstract][Full Text] [Related]
3. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol inhibits vascular smooth muscle cell proliferation.
Sung CP; Arleth AJ; Ohlstein EH
J Cardiovasc Pharmacol; 1993 Feb; 21(2):221-7. PubMed ID: 7679155
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
Fujio H; Nakamura K; Matsubara H; Kusano KF; Miyaji K; Nagase S; Ikeda T; Ogawa A; Ohta-Ogo K; Miura D; Miura A; Miyazaki M; Date H; Ohe T
J Cardiovasc Pharmacol; 2006 Feb; 47(2):250-5. PubMed ID: 16495763
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
7. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
8. Regulation of MAP kinase activity by growth stimuli in vascular smooth muscle.
Langan EM; Youkey JR; Elmore JR; Franklin DP; Singer HA
J Surg Res; 1994 Jul; 57(1):215-20. PubMed ID: 8041141
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury.
Ohlstein EH; Douglas SA; Sung CP; Yue TL; Louden C; Arleth A; Poste G; Ruffolo RR; Feuerstein GZ
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6189-93. PubMed ID: 8327499
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation.
Lai K; Wang H; Lee WS; Jain MK; Lee ME; Haber E
J Clin Invest; 1996 Oct; 98(7):1560-7. PubMed ID: 8833904
[TBL] [Abstract][Full Text] [Related]
11. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
Leduc I; Haddad P; Giasson E; Meloche S
Mol Pharmacol; 1995 Oct; 48(4):582-92. PubMed ID: 7476882
[TBL] [Abstract][Full Text] [Related]
12. High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway.
Nofer JR; Junker R; Pulawski E; Fobker M; Levkau B; von Eckardstein A; Seedorf U; Assmann G; Walter M
Thromb Haemost; 2001 Apr; 85(4):730-5. PubMed ID: 11341512
[TBL] [Abstract][Full Text] [Related]
13. Ceramide 1-phosphate induces neointimal formation via cell proliferation and cell cycle progression upstream of ERK1/2 in vascular smooth muscle cells.
Kim TJ; Kang YJ; Lim Y; Lee HW; Bae K; Lee YS; Yoo JM; Yoo HS; Yun YP
Exp Cell Res; 2011 Aug; 317(14):2041-51. PubMed ID: 21624361
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells.
Yue TL; Wang X; Gu JL; Ruffolo RR; Feuerstein GZ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1442-9. PubMed ID: 7791119
[TBL] [Abstract][Full Text] [Related]
15. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
Li B; Yang L; Shen J; Wang C; Jiang Z
Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
[TBL] [Abstract][Full Text] [Related]
16. Isoeugenodilol inhibits smooth muscle cell proliferation and neointimal thickening after balloon injury via inactivation of ERK1/2 pathway.
Yeh JL; Liou SF; Chang YP; Lin SW; Liu TS; Wu BN; Chen IJ; Wu JR
J Biomed Sci; 2008 May; 15(3):375-89. PubMed ID: 18247158
[TBL] [Abstract][Full Text] [Related]
17. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
Rao YP; Buckley DJ; Buckley AR
Cell Growth Differ; 1995 Oct; 6(10):1235-44. PubMed ID: 8845300
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
Shimokado K; Umezawa K; Ogata J
Exp Cell Res; 1995 Oct; 220(2):266-73. PubMed ID: 7556433
[TBL] [Abstract][Full Text] [Related]
19. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
20. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
Jones DA; Benjamin CW; Linseman DA
Mol Pharmacol; 1995 Nov; 48(5):890-6. PubMed ID: 7476920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
